What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
Turco F, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ekeke Onyeanunam N, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Pablo Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Gillessen S, Omlin A. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology 2022, 82: 6-11. PMID: 35393158, PMCID: PMC8849852, DOI: 10.1016/j.eururo.2022.02.010.Peer-Reviewed Original ResearchConceptsAdvanced Prostate Cancer Consensus ConferenceProstate Cancer Consensus ConferenceAdvanced prostate cancerAdvanced prostate cancer patientsProstate cancerConsensus conferenceVaccinated patientsAPC patientsHigh-risk localised prostate cancerMetastatic hormone-sensitive prostate cancerUnvaccinated patientsHormone-sensitive prostate cancerDeferring radiation therapyExpert treatment recommendationsLocalised prostate cancerProstate cancer managementProstate cancer patientsCOVID-19 vaccineRadiation therapyImmunosuppressive treatmentAltered managementCancer managementCancer patientsTreatment scheduleMale gender
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply